The NMC Generic Prescribing Mandate: What Changed and Why It Matters From 2023, the National Medical Commission (NMC) has made it mandatory for all registered medical practitioners in India to prescribe medicines using generic names rather than brand names. By 2026, this is no longer a soft advisory — compliance is being actively monitored, and doctors who continue to prescribe only by brand names may face action under the NMC’s disciplinary framework. Why this mandate? India is the world’s largest manufacturer of generic medicines. A generic drug has: The same active ingredient In the same strength and dosage form With comparable efficacy and safety as its branded counterpart — but often at 50–90% lower cost. In a country where out-of-pocket health expenditure remains among the highest globally, the way a prescription is written can decide whether a patient completes treatment or abandons it midway. The NMC’s move reframes prescribing as not just a clinical act, but also a social and ethical responsibility. What this means in daily OPD practice In practical terms, generic prescribing requires you to: Write the International Nonproprietary Name (INN) / generic name (e.g., Atorvastatin instead of a specific brand) Specify dose, frequency, route, and duration clearly Avoid restricting the patient to a particular brand unless there is a strong, documented clinical reason Pharmacists can then dispense an appropriate, quality-assured generic (or equivalent) that fits the patient’s budget. Using Jan Aushadhi Kendras effectively The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) network of Jan Aushadhi Kendras offers a wide formulary of quality-tested generics at highly subsidised prices. For OPD practice, this means you can: Check whether the generic you are prescribing is available in the Jan Aushadhi list Guide patients to the nearest Kendra when cost is a barrier Align your prescribing patterns with the PMBJP formulary for common chronic conditions (hypertension, diabetes, dyslipidemia, etc.) This helps ensure that your generic prescription translates into real savings at the pharmacy counter, not just on paper. Addressing patient resistance and misconceptions Many patients equate higher price or a popular brand with better quality. Common concerns include: Jan Aushadhi Kendra: Quick Reference for Doctors What is it? Jan Aushadhi Kendras are government-supported pharmacies under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) that supply quality-assured generic medicines at substantially reduced prices (typically 50–90% cheaper than branded drugs). All medicines are approved by the Central Drugs Standard Control Organisation (CDSCO). What do they stock? >1,900 generic medicines (including antibiotics, cardiovascular, antidiabetic, lipid-lowering, thyroid, analgesics, and many others) Medical devices and surgical consumables Protein supplements and nutraceuticals (Janaushadhi Suvidha range) Common OPD-relevant generics and approximate prices (per strip; prices vary by Kendra and region) | Condition | Generic Name | Approx. Jan Aushadhi Price | |----------------|---------------------|-----------------------------| | Hypertension | Amlodipine 5 mg | ₹2–4 per strip | | Diabetes | Metformin 500 mg | ₹3–8 per strip | | Dyslipidemia | Atorvastatin 10 mg | ₹5–10 per strip | | Hypothyroidism | Levothyroxine 50 mcg| ₹6–12 per strip | | Infection | Amoxicillin 500 mg | ₹10–20 per strip | Clinical use points for prescribing Write prescriptions by generic name, not brand name, so patients can buy from any Jan Aushadhi Kendra. Doses, indications, contraindications, and monitoring are identical to branded equivalents; only the trade name and price differ. Counsel patients that lower price does not mean lower quality; these are CDSCO-approved generics. How patients can locate a Kendra Direct them to the PMBJP website or mobile app to search by city, PIN code, or state. In many tier-2 and tier-3 cities, Kendras are usually located near major hospitals or busy clinic areas. Practical line to add in OPD “Medicines available at Jan Aushadhi Kendra (PMBJP). You may buy from any nearby Kendra by asking for these generic names.” Frequently Asked Questions (SEO Q&A) Q: Is generic prescribing mandatory for all doctors in India? A: Yes. The NMC issued a mandatory directive for all registered medical practitioners to prescribe by generic names. Continued non-compliance can result in disciplinary action under NMC regulations. Q: Are Jan Aushadhi medicines safe and effective? A: Yes. All medicines sold through Jan Aushadhi Kendras are CDSCO-approved, meaning they meet India's regulatory standards for quality, safety, and efficacy. They contain the same active ingredient as branded equivalents. Q: Can a doctor still prescribe a brand name if clinically necessary? A: Yes, with documented clinical justification. For example, narrow therapeutic index drugs (e.g., cyclosporine, lithium, certain antiepileptics) may require brand-specific prescribing due to bioequivalence concerns. This should be explicitly noted on the prescription. Q: What if the patient insists on a branded drug? A: You can note the generic equivalent and let the patient choose. The prescription should still carry the generic name; the patient's choice of brand at the pharmacy is a separate decision. Q: Do generic prescriptions work for online pharmacies in India? A: Yes. All pharmacies — physical and online — are required to honour prescriptions written with generic names. Online pharmacies typically list both generic and brand options at checkout. Q: Where can I find the complete Jan Aushadhi formulary list? A: The updated formulary is available at the official PMBJP website (janaushadhi.gov.in). DocTrust's drug database also cross-references the Jan Aushadhi list to help you flag affordable alternatives during prescribing. How DocTrust Connects with This Generic prescribing is no longer optional — it is a regulatory requirement and an ethical commitment to your patients' financial wellbeing. DocTrust's digital prescribing platform is designed with this in mind: the drug selection workflow defaults to generic names, maps to the Jan Aushadhi formulary, and generates NMC-compliant prescription formats every time. For Indian doctors seeing 40–100+ patients per OPD, manually switching every prescription to a generic format is impractical. DocTrust makes it automatic. You focus on clinical decisions; DocTrust handles compliance and documentation. See how DocTrust can transform your prescribing workflow. Get a demo at www.doctrust.in and take the first step toward a fully compliant, patient-friendly digital clinic.